Back
Reata Pharmaceuticals 10K Form
Buy
67
RETA
Reata Pharmaceuticals
Last Price:
93.69
Seasonality Move:
9.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | RETA/Reata Pharmaceuticals Quarterly |
| 2020-05-11 | 10Q | RETA/Reata Pharmaceuticals Quarterly |
| 2020-02-19 | 10K | RETA/Reata Pharmaceuticals Annual |
| 2019-11-12 | 10Q | RETA/Reata Pharmaceuticals Quarterly |
| 2019-08-08 | 10Q | RETA/Reata Pharmaceuticals Quarterly |
| 2019-05-09 | 10Q | RETA/Reata Pharmaceuticals Quarterly |
Receive RETA News And Ratings
See the #1 stock for the next 7 days that we like better than RETA
RETA Financial Statistics
Sales & Book Value
| Annual Sales: | $2.22M |
|---|---|
| Cash Flow: | $-81.59M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-3.48 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -9.65000 |
|---|---|
| Net Income (TTM): | $-354.18M |
| Gross Margin: | $2.22M |
| Return on Equity: | -38758.59% |
| Return on Assets: | -61.85% |
Reata Pharmaceuticals Earnings Forecast
Key Reata Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 7 years for RETA is 100.00%.
- The Selling, General & Administrative Expenses for RETA have been equal to 4,922.52% of Gross Profit Margin.
- The Research & Development expenses have been 7,650.45% of Revenue.
- The Interest Expense is -13.39% of Operating Income.
- The Net Earning history of RETA is -14,049.55% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 2 years.
Reata Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | RETA |
| CUSIP: | 75615P |
| Website: | reatapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.09 |
| Quick Ratio: | 5.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RETA Technical Analysis vs Fundamental Analysis
Buy
67
Reata Pharmaceuticals (RETA)
is a Buy
Is Reata Pharmaceuticals a Buy or a Sell?
-
Reata Pharmaceuticals stock is rated a Buy
The current Reata Pharmaceuticals [RETA] share price is $94.10. The Score for RETA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.